CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX) IN PATIENTS WITH STAGE II COLON CANCER- MEDICAL AND ECONOMIC BENEFITS

Nov 1, 2002, 00:00
10.1016/S1098-3015(10)61195-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)61195-3/fulltext
Title : CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX) IN PATIENTS WITH STAGE II COLON CANCER- MEDICAL AND ECONOMIC BENEFITS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61195-3&doi=10.1016/S1098-3015(10)61195-3
First page :
Section Title :
Open access? : No
Section Order : 3
Categories :
Tags :
Regions :
ViH Article Tags :